EMA, Aspaveli®

EMA validates indication extension application for Aspaveli® for treatment of C3G and primary IC-MPGN

07.08.2025 - 18:04:37 | prnewswire.co.uk

Swedish Orphan Biovitrum AB Sweden

View original content:https://www.prnewswire.co.uk/news-releases/ema-validates-indication-extension-application-for-aspaveli-for-treatment-of-c3g-and-primary-ic-mpgn-302381200.html

en | boerse | 67981139 |